My Oracle Support Banner

How to configure the different clinical compound numbers in the study? (Doc ID 1671633.1)

Last updated on JULY 13, 2023

Applies to:

Oracle Life Sciences Argus Safety Japan - Version 7.0.2 and later
Information in this document applies to any platform.

Goal

How to configure the different clinical compound numbers in a study?

We need to submit separate E2B (R2) reports to PMDA when the different ingredients (clinical compound numbers) are registered in one study.

Solution

To view full details, sign in with your My Oracle Support account.

Don't have a My Oracle Support account? Click to get started!

In this Document
Goal
Solution


My Oracle Support provides customers with access to over a million knowledge articles and a vibrant support community of peers and Oracle experts.